Sol Langermann

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NXTC

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	NextCure, Inc. (NXTC)	Chief Scientific Officer	$432,242	—	—	$451,900	$95,300	$11,082	$990,524
2021	NextCure, Inc. (NXTC)	Chief Scientific Officer	$406,350	—	—	$865,000	$119,700	$1,932	$1,392,982
2020	NextCure, Inc. (NXTC)	Chief Scientific Officer	$372,673	—	—	$2,031,273	$78,800	$1,941	$2,484,687
2019	NextCure, Inc. (NXTC)	Chief Scientific Officer	$351,633	—	—	—	$106,005	$1,467	$459,105
2018	NextCure, Inc. (NXTC)	Chief Scientific Officer	$340,976	—	—	$455,022	$85,800	$493	$882,291

No earnings-call appearances or filed executive changes recorded yet.